SCALE-C: Strategies for hepatitis C testing and treatment in Aboriginal communities that Lead to Elimination

SCALE-C：原住民社区丙型肝炎检测和治疗策略，最终消除丙型肝炎

• 批准号: nhmrc : GNT1148093
• 负责人: A/Pr Gail Matthews
• 金额: $ 214.51万
• 依托单位: Flinders University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/scale-c-strategies-lead-elimination/1348866
• 关键词: SCALE; Strategies; hepatitis; testing; treatment

Prevalence of hepatitis C infection within the Aboriginal population is among the highest of any identifiable population in Australia. Highly effective, direct-acting antiviral (DAA) therapy, and their listing on the PBS in 2016 has revolutionised HCV clinical management in Australia. The SCALE-C study will evaluate an established test and treat model to rapidly scale-up DAA within four Aboriginal communities to determine both impact on community prevalence and ongoing transmission.

丙型肝炎感染在土著人口中的流行率是澳大利亚任何可识别人口中最高的。高效的直接抗病毒（DAA）疗法于2016年被列入PBS，彻底改变了澳大利亚的HCV临床管理。SCALE-C研究将评估一个已建立的测试和治疗模式，以便在四个土著社区内迅速扩大DAA的规模，以确定对社区患病率和持续传播的影响。